When a Vaccine Safety Trial Becomes Unethical
New vaccines are often evaluated in trials in which some participants receive a placebo. But not all studies can be designed this way.
Related Articles
Deciphering Similarities and Differences in Antifungal and Antibiotic Development
Jatin Vyas, PhD, MD, offers some insights into the economics of development, the biology of fungal species, and the difficulties behind creating new antifungal molecules.
TWiV 1227: How can antibody forget a pandemic?
TWiV reviews the administrations dismantling of the committee that studies pandemic potential, firing of CDC vaccine advisory committee and replacing them with unqualified anti-vaxxers, zoonotic…
Making Care Work for You
HIV treatment is a lifelong commitment to your health and well-being. People who are newly diagnosed with HIV…
mRNA technology makes headway via Pitt, Penn State research
A new kind of mRNA vaccine developed by researchers at the University of Pittsburgh and Penn State University could be cheaper to produce and offer…
How USAID cuts are impacting the fight against HIV in Kenya
The Trump administration’s cuts to the U.S. Agency for International Development have had reverberations around the world. The agency, which operated in over 100 nations…
Testing migrants for key infectious diseases may speed diagnosis, cut risk of spread
In total, 55% of active tuberculosis, 99% of latent tuberculosis, 61% of hepatitis B, 35% of HIV, and 83% of hepatitis C infections were new…
Update from Bernard Mokam
Officials urged residents to avoid anti-Trump protests while they hunt for the gunman, concerned that he might be planning to target the demonstrations after killing…
Wondering about Alberta’s plans for flu and COVID-19 shots? You’re not alone | CBC News
Doctors are warning a messaging void about Alberta’s fall immunization campaign could lead to more COVID-19 and flu infections — and a dramatic strain on…
A new approach to COVID-19 immunizations
Alberta’s government is transitioning its COVID-19 immunization program to a targeted program that prioritizes higher-risk Albertans first and reduces waste.
The Immunology Podcast
Join Drs. Brenda Raud and Jason Goldsmith as they discuss the latest immunology research.
